| Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B OE Olsen, KF Wader, H Hella, AK Mylin, I Turesson, I Nesthus, A Waage, ... Cell communication and signaling 13, 1-7, 2015 | 143 | 2015 |
| TGF-β contamination of purified recombinant GDF15 OE Olsen, A Skjærvik, BF Størdal, A Sundan, T Holien PloS one 12 (11), e0187349, 2017 | 69 | 2017 |
| BMPR2 inhibits activin and BMP signaling via wild-type ALK2 OE Olsen, M Sankar, S Elsaadi, H Hella, G Buene, SR Darvekar, ... Journal of cell science 131 (11), jcs213512, 2018 | 59 | 2018 |
| Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin OE Olsen, KF Wader, K Misund, TK Våtsveen, TB Rø, AK Mylin, ... Blood cancer journal 4 (3), e196-e196, 2014 | 58 | 2014 |
| Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple … M Westhrin, SH Moen, T Holien, AK Mylin, L Heickendorff, OE Olsen, ... haematologica 100 (12), e511, 2015 | 54 | 2015 |
| Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate T Holien, OE Olsen, K Misund, H Hella, A Waage, TB Rø, A Sundan European Journal of Haematology 91 (4), 339-346, 2013 | 46 | 2013 |
| Activins as dual specificity TGF-β family molecules: SMAD-activation via activin-and BMP-type 1 receptors OE Olsen, H Hella, S Elsaadi, C Jacobi, E Martinez-Hackert, T Holien Biomolecules 10 (4), 519, 2020 | 38 | 2020 |
| MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy T Holien, K Misund, OE Olsen, KA Baranowska, G Buene, M Børset, ... Oncotarget 6 (26), 22698, 2015 | 28 | 2015 |
| Address by Governor Oystein Olsen to the Supervisory Council of Norges Bank and invited guests on Thursday 13 February 2014 O Olsen Norges Bank, Oslo, 2014 | 8 | 2014 |
| RNA-Integrity and 8-Isoprostane levels are stable in prostate tissue samples upon long-term storage at− 80 C SA Dybos, ÅW Brustad, T Rolfseng, S Kvam, OE Olsen, J Halgunset, ... Biopreservation and Biobanking 19 (1), 2-10, 2021 | 3 | 2021 |
| High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells C Andersson-Rusch, B Liu, I Quist-Løkken, PD Upton, OE Olsen, H Hella, ... Scientific Reports 13 (1), 6639, 2023 | 2 | 2023 |
| FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells I Quist-Løkken, C Andersson-Rusch, MH Kastnes, JM Kolos, J Jatzlau, ... Cell Communication and Signaling 21 (1), 25, 2023 | 2 | 2023 |
| Correction: MYC amplifications in myeloma cell lines: Correlation with MYC-inhibitor efficacy T Holien, K Misund, OE Olsen, KA Baranowska, G Buene, M Børset, ... Oncotarget 9 (89), 36048, 2018 | 1 | 2018 |
| The role of bone morphogenetic protein-9 in multiple myeloma OE Olsen Institutt for bioteknologi, 2012 | 1 | 2012 |
| Targeting FKBP12 enables bone morphogenetic proteins to kill multiple myeloma cells via ALK2 I Quist-Løkken, C Andersson-Rusch, MH Kastnes, JM Kolos, J Jatzlau, ... | | 2023 |
| First person–Oddrun Elise Olsen OE Olsen Journal of Cell Science 131 (11), 2018 | | 2018 |
| The role of BMP receptor ALK2 in myeloma cells OE Olsen NTNU, 2017 | | 2017 |
| GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels are Associated with Multiple Myeloma Bone Disease M Westrin, SH Moen, T Holien, OE Olsen, AK Mylin, P Gimsing, I Turesson, ... Clinical Lymphoma, Myeloma and Leukemia 15, e231, 2015 | | 2015 |
| GDF15 promotes osteoclast differentiation, inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease M Westhrin, SH Moen, T Holien, AK Mylin, L Heickendorff, OE Olsen, ... | | 2015 |
| GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease M Westhrin, SH Moen, T Holien, OE Olsen, AK Mylin, P Gimsing, ... Blood 124 (21), 2065, 2014 | | 2014 |
